Scholarlink

<p>Vascular endothelial cells and immune cells are lifetime companions by sharing common ancestors and uninterrupted interactions in the circulation. Distribution of immune and inflammatory cells to various tissues and organs is attained by blood flow that travels from large to small vessels. To execute their functions, immune cells cross the vessel wall at least twice through distinct processes of intravasation and extravasation. Anomalous interactions between immune cells and vascular cells may lead to the onset, development, and progression of various diseases, including cancer, cardiovascular disease, metabolic disorders, and inflammatory disease. This review article highlights emerging signaling molecules in modulating interactions between immune cells and endothelial cells under both physiological and pathological conditions. My aim is to provide the updated mechanistic insights into the immune-vascular interface and to discuss possible therapeutic approaches for effective treatment of relevant diseases.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Mechanistic understanding of crosstalk between blood vessels and immunity and inflammation in diseases

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月10日

查看全文
  • Yihai Cao

摘要

Vascular endothelial cells and immune cells are lifetime companions by sharing common ancestors and uninterrupted interactions in the circulation. Distribution of immune and inflammatory cells to various tissues and organs is attained by blood flow that travels from large to small vessels. To execute their functions, immune cells cross the vessel wall at least twice through distinct processes of intravasation and extravasation. Anomalous interactions between immune cells and vascular cells may lead to the onset, development, and progression of various diseases, including cancer, cardiovascular disease, metabolic disorders, and inflammatory disease. This review article highlights emerging signaling molecules in modulating interactions between immune cells and endothelial cells under both physiological and pathological conditions. My aim is to provide the updated mechanistic insights into the immune-vascular interface and to discuss possible therapeutic approaches for effective treatment of relevant diseases.